Home Page | IBRANCE® (palbociclib) | Safety Info
WebBe in. your moment. Thousands of women living with metastatic breast cancer (mBC) are living in the moment—and taking IBRANCE®. IBRANCE is the #1 prescribed, FDA-approved oral combination treatment for HR+, HER2- mBC. Learn More.
Palbociclib - Wikipedia
WebPalbociclib, sold under the brand name Ibrance among others, is a medication developed by Pfizer for the treatment of HR-positive and HER2-negative breast cancer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6 .
palbociclib | Apotheek.nl
WebPalbociclib remt de groei van kankercellen. Hierdoor kunnen tumoren niet verder groeien. Bij borstkanker die gevoelig is voor hormonen. De capsule heel doorslikken met een half glas water. Niet kauwen of open maken. Pas op met grapefruit. Eet of …
palbociclib - Farmacotherapeutisch Kompas
Webpalbociclib vergelijken met een ander geneesmiddel.. Advies. Zie voor de adviezen van de commissie BOM over palbociclib bij mammacarcinoom nvmo.org.. Zie voor de behandeling van borstkanker de geldende behandelrichtlijn op richtlijnendatabase.nl.. ZIN-rapport 2017 palbociclib Ibrance® hormoonreceptor-positieve, HER2-negatieve gevorderde of …
About IBRANCE® (palbociclib) For mBC | Safety Info
WebA Scientific Advancement In The Treatment Of HR+, HER2- Metastatic Breast Cancer. IBRANCE® IS THE FIRST FDA-APPROVED MEDICATION in its class. IBRANCE is a targeted therapy known as a CDK 4/6 inhibitor . It is not a traditional chemotherapy.
Ibrance® | Pfizer
WebIbrance is een geneesmiddel tegen kanker dat de werkzame stof palbociclib bevat. Ibrance wordt gebruikt voor de behandeling van bepaalde typen borstkanker die gevorderd of uitgezaaid zijn. Dat wil zeggen dat de kanker buiten de oorspronkelijke tumor groeit of zich naar andere organen heeft verspreid. Lees hier meer over borstkanker of ga naar ...
Home Page | IBRANCE® (palbociclib) HCP | Safety Info
WebFind the official home page for IBRANCE® in combination with endocrine therapy for certain patients with HR+/HER2- mBC. This site is intended for U.S. healthcare professionals. Visit Pfizer Medical
Ibrance | European Medicines Agency
WebOverview. Ibrance is a cancer medicine used to treat breast cancer when the cancer is locally advanced (has spread nearby) or metastatic (has spread to other parts of the body). Ibrance can only be used when the cancer cells have receptors (targets) for certain hormones on their surface (HR-positive) and do not produce abnormally large ...
Ibrance: Uses, Dosage, Side Effects & Warnings - Drugs.com
WebApr 24, 2024 · Ibrance is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Ibrance is used in men and women to treat HR-positive, HER2-negative breast cancer that has spread to other parts of the body.
Ibrance ( palbociclib - European Medicines Agency
WebIbrance (palbociclib) An overview of Ibrance and why it is authorised in the EU . What is Ibrance and what is it used for? Ibrance is a cancer medicine used to treat breast cancer when the cancer is locally advanced ( has spread nearby) or metastatic (has spread to other parts of the body) . Ibrance can only be used when
Skip to content